Related content

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European––Americans and African––Americans

By Limdi Nita A   Arnett Donna K   Goldstein Joyce A   Beasley T Mark   McGwin Gerald   Adler Brian K   Acton Ronald T  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 511-526

Future Medicine

Access to resources Recommend Favorite

Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic–Americans and African–Americans

By Bress Adam   Patel Shitalben R   Perera Minoli A   Campbell Richard T   Kittles Rick A   Cavallari Larisa H  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1925-1935

Future Medicine

Access to resources Recommend Favorite

Hydroxylation of R (+)- and S (−)-Omeprazole after Racemic Dosing are Different among the CYP2C19 Genotypes

By Shiohira Hideo  

Pharmaceutical Research, Vol. 29, Iss. 8, 2012-08 ,pp. : 2310-2316

Springer Publishing Company

Access to resources Recommend Favorite

Reporting and Interpretation of the CYP2C19 Genotyping Test for Clopidogrel Dosing

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 4, 2010-12 ,pp. : 268-272

Bentham Science Publishers

Access to resources Recommend Favorite

VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African––Americans and European––Americans

By Limdi Nita A   Beasley T Mark   Crowley Michael R   Goldstein Joyce A   Rieder Mark J   Flockhart David A   Arnett Donna K   Acton Ronald T   Liu Nianjun  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1445-1458

Future Medicine

Access to resources Recommend Favorite